What are the diagnostic criteria for acute cholangitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Criteria for Acute Cholangitis

The diagnosis of acute cholangitis requires three components: clinical signs (fever/chills, jaundice, and right upper quadrant abdominal pain), laboratory findings (indicators of inflammation and biliary stasis), and imaging findings (biliary dilatation or evidence of an etiology such as stricture, stone, or obstructing mass). 1, 2

Clinical Manifestations

The classic presentation includes:

  • Fever and/or chills
  • Jaundice
  • Right upper quadrant or epigastric abdominal pain

This triad (Charcot's triad) has been historically used but has inadequate sensitivity when used alone 3, 4. You cannot rely solely on clinical signs—laboratory and imaging confirmation are essential.

Laboratory Findings Required

You must document both of the following:

  • Indicators of inflammation: Elevated white blood cell count, elevated C-reactive protein, or other inflammatory markers
  • Indicators of biliary stasis: Elevated bilirubin, alkaline phosphatase, gamma-glutamyl transferase (GGT), or transaminases

The 2018 Tokyo Guidelines validated that these combined criteria provide 87.6% sensitivity and 77.7% specificity 5, 6.

Imaging Findings Required

Imaging must demonstrate at least one of:

  • Biliary dilatation (intrahepatic or extrahepatic)
  • Evidence of the etiology: stone, stricture, stent, or obstructing mass

Imaging Algorithm

Initial imaging: Start with abdominal ultrasound in non-pregnant adults 1, 2. While ultrasound is the recommended first-line modality, the evidence supporting this is very low certainty and relies on indirect evidence from acute cholecystitis studies, as no direct studies assessed ultrasound accuracy for cholangitis 1.

If ultrasound is equivocal: Proceed to CT with IV contrast 1, 2.

If both ultrasound and CT are inconclusive: MRI/MRCP is the reasonable next step 1.

In pregnant patients: Either ultrasound or MRI can be considered as initial imaging, though guidelines acknowledge this as a knowledge gap with no clear preference 1, 2.

Critical Exclusions

You must exclude cholecystitis and acute pancreatitis as alternative diagnoses 3. The BILE criteria (Biliary imaging abnormalities or recent intervention, Inflammatory test abnormalities, Liver test abnormalities, and Exclusion of cholecystitis/pancreatitis) represent a simplified approach that identifies high-risk patients, though this requires prospective validation 3.

Common Pitfalls

  • Do not diagnose cholangitis on clinical grounds alone—the traditional Charcot's triad has poor sensitivity and will miss cases 3, 4
  • Do not skip imaging—biliary obstruction must be documented radiographically 1
  • Do not confuse diagnostic criteria with severity grading—once diagnosed, separate severity assessment (Grade I-III) guides treatment intensity and timing of biliary drainage 5, 6, 4
  • In children: Mirror the adult imaging pathway, though evidence is limited as cholangitis is uncommon in pediatric populations 1, 2

Severity Grading After Diagnosis

Once diagnosed, classify severity to guide management:

  • Grade III (Severe): Presence of organ dysfunction—requires urgent biliary drainage
  • Grade II (Moderate): No organ dysfunction but fails to respond to initial medical treatment—early biliary drainage improves 30-day mortality 5
  • Grade I (Mild): Responds to initial medical treatment

The Tokyo Guidelines 2018 criteria are validated, minimally invasive, inexpensive, and provide rapid results, making them the current standard 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.